86 - The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-< 70 years old.

Thursday, October 17, 2024

11:30 AM – 11:45 AM US PT

Location: 404 AB

Presenting Author(s)

Charlie McLeod, PhD, MBBS (Hons), FRACP, DTMH, DCH

ID consultant/Deputy Director Wesfarmers Centre of Vaccines and Infectious Diseases
Telethon Kids Institute
Perth, Western Australia, Australia

Slides

Co-Author(s)

MD

Michael Dymock, BSc

Telethon Kids Institute
Perth, Western Australia, Australia
KF

Katie Flanagan, PhD

Launceston General Hospital
Launceston, Tasmania, Australia
MP

Magdalena Plebanski, PhD

Royal Melbourne Institute of Technology University (RMIT)
Melbourne, Victoria, Australia
HM

Helen Marshall, MD

University of Adelaide
Adelaide, South Australia, Australia
ME

Marie Estcourt, PhD

University of Sydney
Sydney, New South Wales, Australia
UW

Ushma Wadia, MBBS

Telethon Kids Institute
Perth, Western Australia, Australia
CT

Christian Tjiam, PhD

Telethon Kids Institute
Perth, Western Australia, Australia
Christopher C. Blyth, MBBS(Hons), DCH, FRACP, FRCPA, PhD (he/him/his)

Professor and Director
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute
Nedlands, Western Australia, Australia
Kanta Subbarao, MBBS, MPH

Director,
WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
Melbourne, Victoria, Australia
FM

Francesca Mordant, PhD

Doherty Institute
Melbourne, Victoria, Australia
SN

Suellen Nicholson, BSci

University of Melbourne
Melbourne, Victoria, Australia
Saul N. Faust, FRCPCH PhD (he/him/his)

Professor of Paediatric Immunology and Infectious Diseases
University of Southampton and University Hospital Southampton NHS Foundation Trust
Southampton, England, United Kingdom
RT

Ruth Thornton, PhD

Telethon Kids Institute
Perth, Western Australia, Australia
AM

Anne McKenzie, Consumer Expert

Telethon Kids Institute
Perth, Western Australia, Australia
JM

Julie Marsh, PhD

Telethon Kids Institute
Perth, Western Australia, Australia
Thomas L. Snelling, BMBS, DTMH, GDipClinEpid, PhD, FRACP

Professor of Infectious Diseases and Director of the Health and Clinical Analytics lab
University of Sydney
Sydney, New South Wales, Australia
PR

Peter Richmond, MBBS

University of Western Australia School of Medicine, Perth’s Children Hospital
Nedlands, Western Australia, Australia

Disclosure(s):

Charlie McLeod, PhD, MBBS (Hons), FRACP, DTMH, DCH: No financial relationships to disclose

Michael Dymock, BSc: No financial relationships to disclose

Katie Flanagan, PhD: No financial relationships to disclose

Magdalena Plebanski, PhD: AstraZeneca: Grant/Research Support

Helen Marshall, MD: ILiAD biotechnologies: Grant/Research Support

Marie Estcourt, PhD: No financial relationships to disclose

Ushma Wadia, MBBS: No financial relationships to disclose

Christian Tjiam, PhD: No financial relationships to disclose

Christopher C. Blyth, MBBS(Hons), DCH, FRACP, FRCPA, PhD: No financial relationships to disclose

Kanta Subbarao, MBBS, MPH: No financial relationships to disclose

Francesca Mordant, PhD: No financial relationships to disclose

Suellen Nicholson, BSci: No financial relationships to disclose

Saul N. Faust, FRCPCH PhD: AstraZeneca: Grant/Research Support; BioNTech: Grant/Research Support; GSK: Grant/Research Support; Iliad Biotechnologies: Grant/Research Support; J&J: Advisor, no personal payments (all honoraria paid to employing hospital), Grant/Research Support; Moderna: Grant/Research Support; Novavax: Advisor, no personal payments (all honoraria paid to employing hospital); Pfizer: Advisor, no personal payments (all honoraria paid to employing hospital); Sanofi: Advisor, no personal payments (all honoraria paid to employing hospital), Grant/Research Support; Valneva: Grant/Research Support

Ruth Thornton, PhD: No financial relationships to disclose

Anne McKenzie, Consumer Expert: No financial relationships to disclose

Julie Marsh, PhD: No financial relationships to disclose

Thomas L. Snelling, BMBS, DTMH, GDipClinEpid, PhD, FRACP: No financial relationships to disclose

Peter Richmond, MBBS: ILiAD biotechnologies: Grant/Research Support